PDF-Transcatheter

aortic valve implantation for failed surgical aortic bioprostheses using a self expanding device early results from the prospective VIVA post market study Prof Ran Kornowski Rabin Medical C. RQLQNOLMNH573473KLOLSV57347OHFWURQLFV573471573619 3KLOLSV57347HDOWKFDUH57347UHVHUYHV57347WKH57347ULJKW57347WR57347PDNH57347FKDQJHV57347LQ57347VSHFL57536FDWLRQV57347DQG57362RU57347WR57347GLVFRQWLQXH57347DQ57347SURGXFW57347DW57347DQ57347WLPH57347ZLWKRX MATERIALS AND METHODS Fortyseven cancer patients re ferred to our catheterization laboratory for retrieval of the fractured PortA ca theter were enrolled from January 2005 to March 2006 The procedures were performed under hospital basis and the pati . What can be safely done?. Jonas D. Del Rosario, MD, FPCC. Clinical Associate Professor. UP College of Medicine. No disclosures. First DO NO HARM. Objectives. What types of VSD are amenable for catheter closure at this time. with surgeons and interventionalists to develop the next generation of synthetic cardiovascular devices. From expandable vascular grafts to synthetic transcatheter valves, PECA Labs focuses on imp Operators:. Samin K Sharma, MD, FACC, . MSCAI. Annapoorna Kini, MD, MRCP, FACC. Gilbert Tang, MD, MSc, MBA, FACC. Sahil Khera, MD, MPH, FACC. Parasuram Krishnamoorthy, MD. Echocardiographer: . Stamatios Lerakis, MD, PhD, FACC, FAHA. Therapy and Maximising TAVI Programme Leveraging unique advantages of a TAVI portfolio for optimised outcomes and early discharge cardiovascularnews.com This educational supplement has been spo ”. Muhammad Raza, MD, FACC, FSCAI, RPVI.. Interventional cardiologist. Director, Cardiac Cath Lab, . Crozer. Chester Medical Center,. Upland, PA. . Disclosure. Consultant and Proctor – Medtronic. Neil Tailor, MD. 1. ; Ranjit Philip, MD. 1. ; Evan Harvey, MD. 1. ; Genevieve . DuPuis. , CRNA. 2. ; B. Rush Waller, MD. 1. ; Nathan . Stecchi. , RDCS. 3. ; Shyam Sathanandam, MD. 1. ..  . 1. Division of Pediatric Cardiology, . The Randomized MITHRAS Trial. . Philipp . Lurz. , Matthias . Unterhuber. , Karl-Philipp Rommel, Karl-. Patrik. . Kresoja. , . Tobias . Kister. , Christian Besler, Karl . Fengler. , Marcus Sandri, Ingo . Adam Greenbaum, MD. Emory University Hospital, Atlanta. @AdamGreenbaumMD. On behalf of the CLASP TR . study investigators. Speaker Disclosures . Speaker’s name: Adam Greenbaum, MD. ☑ I have the . Lyndon C. Box, MD FSCAI. West Valley Cardiology, Caldwell ID. On behalf of the authors, SCAI Executive Committee and the SCAI Government Relations Committee. Disclosures. NONE. Why?. Centers for Medicaid and Medicare Services, . Gregg W. Stone, MD. On behalf of Michael Mack, William Abraham, JoAnn Lindenfeld . and the COAPT Investigators. Gregg W. Stone MD. Consulting fees from . Neovasc. , Valfix, Gore. Equity/options in . Ancora. Valve. . Replacement. . with. . the. . Tendyne. . valve. The . Tendyne. mitral valve system. (. Figure. 1). A. : . The . nitinol. self-expanding prosthesis has a double flame. An outer flame (arrow) contains a cuff and an inner flame has a . Gregory Condos, MD, LCDR, MC, USN; Katherine Rees; Rasleen Grewal; Hirsch Mehta, MD; Raghava Gollapudi, MD; Karl Limmer, MD; Arvin Narula, MD. Disclosures. The authors have no relevant financial disclosures..